Evaluation of Destructive Effects of Exposure to Cisplatin During Developmental Stage: No Profound Evidence for Sex Differences in Impaired Motor and Memory Performance

REFERENCES

• Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer. 2002;3:84–90.
   PubMedGoogle Scholar
• Correa DD, Ahles TA, Neurocognitive changes in cancer survivors. Cancer J. 2008;14(6):396–400.
   PubMed Web of Science ®Google Scholar
• Prestayko AW, D'Aoust JC, Issell BF, Crooke ST. Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev. 1979;6(1):17–39.
   PubMed Web of Science ®Google Scholar
• Screnci D, McKeage MJ. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches. J Inorg Biochem. 1999;77(1–2):105–110.
   PubMedGoogle Scholar
• Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D, Johnson DH. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594. Cancer. 2001;92(10):2639–2647.
   PubMedGoogle Scholar
• Paksoy M, AE, Sanlı A, Eken M, Aydın S, Oktay ZA. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol. 2011;28(2):615–621.
   PubMed Web of Science ®Google Scholar
• Gallo JM, Laub PB, Rowinsky EK, Grochow LB, Baker SD. Population pharmacokinetic model for topotecan derived from phase I clinical trials. J Clin Oncol., 2000;18(12):2459–2467.
   PubMed Web of Science ®Google Scholar
• Loos WJ, Gelderblom H, Verweij J, van Boven-van Zomeren DM, Nooter K, Stoter G, Sparreboom A. Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis. Anti-Cancer Drugs. 2003;14(3):227–232.
   PubMed Web of Science ®Google Scholar
• Wall AM, Gajjar A, Link A, Mahmoud H, Pui CH, Relling MV. Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia. Leukemia. 2000;14(2):221–225.
   PubMedGoogle Scholar
• Morris ME, Lee HJ, Predko LM. Gender differences in the membrane transport of endogenous and exogenous compounds. Pharmacol Rev. 2003;55(2):229–240.
   PubMedGoogle Scholar
• Mihalick SM. Perinatal exposure to diethylstilbestrol improves olfactory discrimination learning in male and female Swiss-Webster mice. Neurobiol Learn Mem. 2003;80(1):55–62.
   PubMedGoogle Scholar
• Argyriou AA, Polychronopoulos P, Koutras A, Xiros N, Petsas T, Argyriou K, Kalofonos HP, Chroni E. Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel based chemotherapy. Eur J Cancer Care 2007;16(3):231–237.
   PubMedGoogle Scholar
• Yalcin S, NG, Orhan B, Zeybek D, Müftüoğlu S, Sarer B, Yildirim BA, Cetin E. Protective effect of amifostine against cisplatin-induced motor neuropathy in rat. Med Oncol. 2003;20(2):175–180.
   PubMed Web of Science ®Google Scholar
• Shabani M, Hosseinmardi N, Haghani M, Shaibani V, Janahmadi M. Maternal exposure to the CB1 cannabinoid agonist WIN 55212–2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurones in rat offspring. Neuroscience. 2011;13(172):139–152.
   Google Scholar
• Van Wijk N, Rijntjes E, Van De Heijning B. Perinatal and chronic hypothyroidism impair behavioural development in male and female rats. Exp Physiol. 2008;93(11):1199–1209.
   PubMedGoogle Scholar
• Frick KM, Stillner ET, Berger-Sweeney J. Mice are not little rats: species differences in a one-day water maze task. Neuroreport. 2000;11(16):3461–3465.
   PubMedGoogle Scholar
• Rzeski W, Pruskil S, Macke A, Felderhoff-Mueser U, Reiher AK, Hoerster F, Jansma C, Jarosz B, Stefovska V, Bittigau P, Ikonomidou C. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol. 2004;56(3):351–360.
   PubMedGoogle Scholar
• Hill A, Bergin P, Hanning F, Thompson P, Findlay M, Damianovich D, McKeage MJ. Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability. BMC Cancer. 2010;10(1):451.
   PubMedGoogle Scholar
• Bottone MG, Soldani C, Veneroni P, Avella D, Pisu M, Bernocchi G. Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment. Cell Proliferat. 2008;41(3):506–520.
   PubMedGoogle Scholar
• Pisu MB, Roda E, Guioli S, Avella D, Bottone MG, Bernocchi G. Proliferation and migration of granule cells in the developing rat cerebellum: cisplatin effects. Anat Rec A Discov Mol Cell Evol Biol. 2005;287(2):1226–1235.
   PubMedGoogle Scholar
• Pisu MB, Guioli S, Conforti E, Bernocchi G. Signal molecules and receptors in the differential development of cerebellum lobules. Acute effects of cisplatin on nitric oxide and glutamate systems in Purkinje cell population. Brain Res Dev Brain Res. 2003;145(2):229–240.
   PubMedGoogle Scholar
• Pisu MB, Roda E, Avella D, Bernocchi G. Developmental plasticity of rat cerebellar cortex after cisplatin injury: inhibitory synapses and differentiating Purkinje neurons. Neuroscience. 2004;129(3):655–664.
   PubMedGoogle Scholar
• Avella D, Pisu MB, Roda E, Gravati M, Bernocchi G. Reorganization of the rat cerebellar cortex during postnatal development following cisplatin treatment. Exp Neurol. 2006;201(1):131–143.
   PubMedGoogle Scholar
• Scherini E, Bernocchi G. CisDDP treatment and development of the rat cerebellum. Prog Neurobiol. 1994;42(2): 161–196.
   PubMedGoogle Scholar
• Malik NM, Moore GB, Smith G, Liu YL, Sanger GJ, Andrews PL. Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: a model of chemotherapy-related malaise? Pharmacol Biochem Behav. 2006;83(1):9–20.
   PubMedGoogle Scholar
• Zwelling L, Kohn K. Mechanism of action of cis-dichlorodiammineplatinum (II). Cancer Treat Rep. 1979;63(9–10):1439–1444.
   PubMedGoogle Scholar
• Wick A, Wick W, Hirrlinger J, Gerhardt E, Dringen R, Dichgans J, Weller M, Schulz JB. Chemotherapy induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity. J Neurochem. 2004;91(5):1067–1074.
   PubMedGoogle Scholar
• Roda E, Avella D, Pisu MB, Bernocchi G. Monoamine receptors and immature cerebellum cytoarchitecture after cisplatin injury. J Chem Neuroanat. 2007;33(1):42–52.
   PubMedGoogle Scholar
• Hajali V, Sheibani V, Esmaeili-Mahani S, Shabani M. Female rats are more susceptible to the deleterious effects of paradoxical sleep deprivation on cognitive performance. Behav Brain Res. 2012;228(2):311–318.
   PubMed Web of Science ®Google Scholar
• Barnett RC, Biener LE, Baruch GK. Gender and stress. New York, NY: Free Press; 1987. xii 386 pp.
   Google Scholar
• Allen JS, Damasio H, Grabowski TJ, Bruss J, Zhang W. Sexual dimorphism and asymmetries in the gray-white composition of the human cerebrum. Neuroimage. 2003;18(4):880–894.
   PubMed Web of Science ®Google Scholar
• Madeira MD, Lieberman, AR. Sexual dimorphism in the mammalian limbic system. Prog Neurobiol. 1995;45(4):275–333.
   PubMed Web of Science ®Google Scholar
• El-Shazly M, Afify M, El-Dieb M. Histopathological study into side-effect toxicity of some drugs used in treatment of cancer. Archiv fuer experimentelle Veterinaermedizin. 1989;43(2):319–326.
   PubMedGoogle Scholar
• Sartelet H, Oligny LL, Vassal G. AKT pathway in neuroblastoma and its therapeutic implication. Expert Rev Anticancer Ther. 2008;8(5):757–769.
   PubMed Web of Science ®Google Scholar
• Troy L, McFarland K, Littman-Power S, Kelly BJ, Walpole ET, Wyld D, Thomson D. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology. 2000;9(1):29–39.
   PubMedGoogle Scholar
• Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FS, Koolhaas JM, Buwalda B. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res. 2008;186(2):168–175.
   PubMed Web of Science ®Google Scholar
• Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008;19(4):623–629.
   PubMed Web of Science ®Google Scholar
• Song TY, Chen CL, Liao JW, Ou HC, Tsai MS. Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo. Food Chem Toxicol. 2010;48:3492–3499.
   PubMed Web of Science ®Google Scholar
• Joerg D, Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 2006;5(7):22.
   PubMedGoogle Scholar
• Bantel H, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res. 1999;59(9):2083–2090.
   PubMedGoogle Scholar
• Kebieche M, Lakroun Z, Lahouel M, Bouayed J, Meraihi Z, Soulimani R. Evaluation of epirubicin-induced acute oxidative stress toxicity in rat liver cells and mitochondria, and the prevention of toxicity through quercetin administration. Exp Toxicol Pathol. 2009;61(2):161–167.
   PubMedGoogle Scholar
• Geller HM, Cheng KY, Goldsmith NK, Romero AA, Zhang AL, Morris EJ, Grandison L. Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside. J Neurochem. 2001;78(2):265–275.
   PubMedGoogle Scholar
• Yang M, Kim JS, Song MS, Kim SH, Kang SS, Bae CS, Kim JC, Wang H, Shin T, Moon C. Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits. Neurobiol Learn Mem. 2010;93(4):487–494.
   PubMed Web of Science ®Google Scholar